The Ins and Outs of Insolvency | GenomeWeb

Jeremy Grushcow at The Cross-Border Biotech Blog breaks down how the recent amendments to Canada’s insolvency legislation pertain to intellectual property licenses. He writes that unlike in the U.S., where Section 365 (n) of the bankruptcy code protects licensees in the event that that licensor becomes insolvent, Canadian law has not offered such protection in the past.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.